Peptide Development Labs Inc.
Peptide Development Labs Inc. is a Canadian pharmaceutical development company focused on advancing investigational peptide-based drug candidates through established regulatory pathways. The Issuer’s mission is to develop peptide candidates that may address defined areas of unmet clinical need within a conventional pharmaceutical framework. To achieve this, the Issuer focuses on advancing its investigational subcutaneous BPC-157 drug candidate for refractory ligament disorders through GMP-controlled supply, pharmaceutical quality systems, physician-led access, structured data generation and formal clinical development.